ELTROMBOPAG tablets, for oral use
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2026-01-14
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 21:55:49
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1245001 | eltrombopag 12.5 MG Oral Tablet | PSN | 1 |
| 825421 | eltrombopag 25 MG Oral Tablet | PSN | 1 |
| 825427 | eltrombopag 50 MG Oral Tablet | PSN | 1 |
| 884617 | eltrombopag 75 MG Oral Tablet | PSN | 1 |
| 1245001 | eltrombopag 12.5 MG Oral Tablet | SCD | 1 |
| 825421 | eltrombopag 25 MG Oral Tablet | SCD | 1 |
| 825427 | eltrombopag 50 MG Oral Tablet | SCD | 1 |
| 884617 | eltrombopag 75 MG Oral Tablet | SCD | 1 |
| 1245001 | eltrombopag (as eltrombopag olamine) 12.5 MG Oral Tablet | SY | 1 |
| 825421 | eltrombopag (as eltrombopag olamine) 25 MG Oral Tablet | SY | 1 |
| 825427 | eltrombopag (as eltrombopag olamine) 50 MG Oral Tablet | SY | 1 |
| 884617 | eltrombopag (as eltrombopag olamine) 75 MG Oral Tablet | SY | 1 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ELTROMBOPAG Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 349df11e-99eb-4fff-8cd5-538adda21b14 | Product name | 3 | 20251110 |
| 4db6dd95-5e83-4752-b5e1-62f824423c50 | Product name | 1 | 20241217 |
| fa996cde-a51d-4f68-1429-4f06c00a39f8 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1925-3 | ELTROMBOPAG | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 70771-1926-3 | ELTROMBOPAG | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 70771-1927-3 | ELTROMBOPAG | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 70771-1927-7 | ELTROMBOPAG | 14 in 1 BOTTLE | TABLET | 14 | 1 | |
| 70771-1928-3 | ELTROMBOPAG | 30 in 1 BOTTLE | TABLET | 30 | 1 |
Products#
Every source-derived product name is available through these pages.
- ELTROMBOPAG
- ELTROMBOPAG OLAMINE
- HYPROMELLOSE 2910 (6 MPA.S)
- MICROCRYSTALLINE CELLULOSE 101
- POLYETHYLENE GLYCOL 400
- POVIDONE K30
- SODIUM STARCH GLYCOLATE TYPE A POTATO
- SODIUM STEARYL FUMARATE
- TITANIUM DIOXIDE
- XYLITOL
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FD&C BLUE NO. 2--ALUMINUM LAKE
- FERROSOFERRIC OXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1925 | 70771-1925-3 |
| 70771-1926 | 70771-1926-3 |
| 70771-1927 | 70771-1927-7, 70771-1927-3 |
| 70771-1928 | 70771-1928-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216281-001 | ELTROMBOPAG OLAMINE | ELTROMBOPAG OLAMINE | EQ 12.5MG ACID | TABLET / ORAL | AB | 2026-01-14 | |
| A216281-002 | ELTROMBOPAG OLAMINE | ELTROMBOPAG OLAMINE | EQ 25MG ACID | TABLET / ORAL | AB | 2026-01-14 | |
| A216281-003 | ELTROMBOPAG OLAMINE | ELTROMBOPAG OLAMINE | EQ 50MG ACID | TABLET / ORAL | AB | 2026-01-14 | |
| A216281-004 | ELTROMBOPAG OLAMINE | ELTROMBOPAG OLAMINE | EQ 75MG ACID | TABLET / ORAL | AB | 2026-01-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216281-001 | AB |
| A216281-002 | AB |
| A216281-003 | AB |
| A216281-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216281-001 | ELTROMBOPAG OLAMINE | EQ 12.5MG ACID | TABLET / ORAL | AB | 2026-01-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A216281-002 | ELTROMBOPAG OLAMINE | EQ 25MG ACID | TABLET / ORAL | AB | 2026-01-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A216281-003 | ELTROMBOPAG OLAMINE | EQ 50MG ACID | TABLET / ORAL | AB | 2026-01-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A216281-004 | ELTROMBOPAG OLAMINE | EQ 75MG ACID | TABLET / ORAL | AB | 2026-01-14 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A216281-001 | ELTROMBOPAG OLAMINE | EQ 12.5MG ACID | TABLET / ORAL | AB | 2026-01-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A216281-002 | ELTROMBOPAG OLAMINE | EQ 25MG ACID | TABLET / ORAL | AB | 2026-01-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A216281-003 | ELTROMBOPAG OLAMINE | EQ 50MG ACID | TABLET / ORAL | AB | 2026-01-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A216281-004 | ELTROMBOPAG OLAMINE | EQ 75MG ACID | TABLET / ORAL | AB | 2026-01-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-001 | ELTROMBOPAG OLAMINE | EQ 12.5MG ACID | TABLET / ORAL | AB | 2026-01-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-002 | ELTROMBOPAG OLAMINE | EQ 25MG ACID | TABLET / ORAL | AB | 2026-01-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-003 | ELTROMBOPAG OLAMINE | EQ 50MG ACID | TABLET / ORAL | AB | 2026-01-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-004 | ELTROMBOPAG OLAMINE | EQ 75MG ACID | TABLET / ORAL | AB | 2026-01-14 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-001 | ELTROMBOPAG OLAMINE | EQ 12.5MG ACID | TABLET / ORAL | AB | 2026-01-14 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-002 | ELTROMBOPAG OLAMINE | EQ 25MG ACID | TABLET / ORAL | AB | 2026-01-14 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-003 | ELTROMBOPAG OLAMINE | EQ 50MG ACID | TABLET / ORAL | AB | 2026-01-14 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-004 | ELTROMBOPAG OLAMINE | EQ 75MG ACID | TABLET / ORAL | AB | 2026-01-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216281-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A216281-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A216281-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A216281-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A216281-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A216281-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A216281-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A216281-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A216281-004 | AB | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216281-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ELTROMBOPAG | ELTROMBOPAG | Zydus Lifesciences Limited | ae9a7725-64f8-406d-88e7-e6e01136deae | 2026-01-14 | 70771-1926-3 70771-1928-3 70771-1927-7 70771-1925-3 70771-1927-3 70771-1927 70771-1928 70771-1925 70771-1926 70771192603 70771192707 70771192703 70771192503 70771192803 5273da92-fa13-4b26-b32f-63955b1983c3 ae9a7725-64f8-406d-88e7-e6e01136deae |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



